Bill > HB533

This bill authorizes pharmacists to test for and treat minor, nonchronic health conditions, which are defined as short-term ailments typically managed with non-controlled drugs, minimal treatment, or self-care, including conditions like influenza, strep throat, COVID-19, urinary tract infections, and certain skin conditions. It also allows pharmacists to delegate the technical aspects of certain tests, like those qualifying for a waiver under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), to pharmacy interns or technicians under their supervision. Furthermore, the bill prohibits health insurance plans from denying reimbursement for services a pharmacist provides that are within their scope of practice and would be covered if performed by a physician, advanced practice registered nurse, or physician assistant. Importantly, it expands the definition of the "practice of pharmacy" to explicitly include ordering, performing, and interpreting certain tests, as well as initiating, administering, or modifying drug therapy, aligning with the growing role of pharmacists in patient care. The bill also references existing law regarding step therapy or fail-first protocols, which are insurance requirements that patients must try a specific drug before another is covered, and outlines procedures for overriding these protocols when medically necessary.

Health and Social Services

https://billstatus.ls.state.ms.us/2026/pdf/history/HB/HB0533.xml